Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00054431
Status:
COMPLETED
Last Update Posted:
2013-01-23
First Post:
2003-02-05
Brief Title:
Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Relapsing Chronic Myelogenous Leukemia |
| Accelerated Phase Chronic Myelogenous Leukemia |
| Blastic Phase Chronic Myelogenous Leukemia |
| Childhood Chronic Myelogenous Leukemia |
| Chronic Myelogenous Leukemia BCR-ABL1 Positive |
Keywords: